Directory
>
Fred Vogt
Fred Vogt
Interim CEO and General Counsel | Iovance Biotherapeutics, Inc.
Pennsylvania, United States
Fred Vogt
Summary
Fred Vogt is an accomplished professional with extensive expertise in intellectual property law, particularly in patent law and litigation, alongside a strong background in biochemistry and biotechnology. Currently serving as the Interim CEO and General Counsel at Iovance Biotherapeutics, he combines his legal acumen with a deep understanding of the life sciences sector. With a Ph.D. in Chemistry and a J.D. from Temple University, Fred has held various influential roles, including patent attorney and manager at GlaxoSmithKline, where he led teams in the development of innovative therapeutic solutions. His academic contributions include numerous publications in prestigious journals, showcasing his commitment to advancing scientific knowledge. Fred is known for his ability to bridge the gap between complex scientific principles and legal frameworks, making him a valuable asset in any organization. His leadership experience spans both corporate and academic environments, reflecting a versatile career dedicated to excellence in the life sciences and legal fields.
Fred Vogt
Work Experience
Interim CEO and General Counsel at
Iovance Biotherapeutics, Inc.
September 2016 - Present
Associate Patent Attorney at
Morgan Lewis & Bockius LLP
May 2013 - September 2016
Adjunct Professor of Chemistry at
Villanova
August 2004 - June 2013
Patent Attorney/Manager, Product Development at
GSK
June 2000 - May 2013
Chemist at
Betz Laboratories
January 1995 - August 1995
Fred Vogt
Education
Temple University, Doctor Of Law (J.D.)
January 2008 - January 2012
Penn State University, Doctor Of Philosophy (Ph.D.)
January 1995 - January 2000
Ursinus College, Bachelor Of Science (B.S.)
January 1991 - January 1995
Frequently Asked Questions about Fred Vogt
What is Fred Vogt email address?
Fred Vogt's primary email address is *********@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Fred Vogt work for?
Fred Vogt is a Interim CEO and General Counsel at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.
Where Fred Vogt graduated from?
Fred Vogt holds a degree in from Temple University.
How can I directly contact Fred Vogt?
To contact Fred Vogt directly, you can use the email address *********@iovance.com. Complete contact information is available upon registration with Muraena.
Who is Fred Vogt?
Fred Vogt is an accomplished professional with extensive expertise in intellectual property law, particularly in patent law and litigation, alongside a strong background in biochemistry and biotechnology. Currently serving as the Interim CEO and General Counsel at Iovance Biotherapeutics, he combines his legal acumen with a deep understanding of the life sciences sector. With a Ph.D. in Chemistry and a J.D. from Temple University, Fred has held various influential roles, including patent attorney and manager at GlaxoSmithKline, where he led teams in the development of innovative therapeutic solutions. His academic contributions include numerous publications in prestigious journals, showcasing his commitment to advancing scientific knowledge. Fred is known for his ability to bridge the gap between complex scientific principles and legal frameworks, making him a valuable asset in any organization. His leadership experience spans both corporate and academic environments, reflecting a versatile career dedicated to excellence in the life sciences and legal fields.
Fred`s contact details
*********@iovance.com
***********@gsk.com
Colleagues
Executive Director, Clinical Development, Oncology
Vice President, Cell Therapy Account Teams
Senior Vice President, Medical Affairs
Vice President, Research Alliances
Chief Medical Officer
Executive Director
SVP Head of Digital and Information Technology
Vice President, Regulatory Affairs
Executive Director, CMC Biostatistics
VP, Global Commercial Operations